Market Overview:
The global API contract manufacturing market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for generic drugs, rising number of biologics approvals, and growing outsourcing trend by pharmaceutical companies.
The global API contract manufacturing market is segmented on the basis of type into commercial manufacturing and clinical manufacturing. Commercial Manufacturing is further sub-segmented into small molecule APIs and large molecule APIs while Clinical Manufacturing is further sub-segmented into sterile APIs and non-sterile APIs. On the basis of application, the global API contract manufacturing market is segmented into oncology, central nervous system (CNS), cardiovascular disorder, infectious diseases, pulmonary disorders, metabolic disorder Gastrointestinal disorders Musculoskeletal disorders Genitourinary disorders among others. Geographically, the global API contractmanufacturingmarketis segmentedinto North America Latin America Europe Asia Pacificand Middle East & Africa (MEA). North America dominatestheglobalAPIcontractmanufacturingmarketdue tothe presenceofmajorpharmaceuticalcompaniesinthisregionandhighdemandforgenericdrugsduetothepresenceof stringent regulatory framework governing drug approvals in this region .
Product Definition:
API Contract Manufacturing is a process by which a company manufactures an active pharmaceutical ingredient (API) for another company. This process can be done in-house or outsourced to a contract manufacturer. The importance of API Contract Manufacturing lies in the fact that it allows companies to focus on their core competencies and leaves the manufacturing of APIs to those with the appropriate expertise and facilities.
Commercial Manufacturing:
API Contract Manufacturing is a service where the manufacturer produces raw materials and API products as per the client’s specifications. The contract manufacturing services are used by various end-use industries such as healthcare, cosmetics, and agriculture among others. End-users find it cost effective to outsource their production activities due to low labor costs involved in performing these tasks.
Increasing demand for customized medicines coupled with growing R&D expenditure is expected to drive market growth over the forecast period.
Clinical Manufacturing:
API Contract Manufacturing market is expected to grow at a significant rate owing to the increasing demand for specialty drugs coupled with rising R&D expenditure. The contract manufacturing market is expected to witness growth over the forecast period due to various factors such as growing focus on value-added services, cost efficiency, and expertise.
The shift in trend towards outsourcing pharmaceutical manufacturing activities has led many companies into investing heavily in contract manufacturing organizations (CMOs) or clinical production facilities.
Application Insights:
The oncology segment dominated the global API contract manufacturing market in 2017. This can be attributed to increasing cancer prevalence and mortality rates. According to WHO, around 1 in 6 deaths occur due to cancer worldwide. In addition, new drug development for oncology is very expensive and time-consuming process that requires a high level of precision during production process. Thus, companies are opting for commercial or clinical-grade facilities depending upon their requirements as both provide same level of quality but differ with respect to price and efficiency offered by them.
Regional Analysis:
Asia Pacific is expected to be the fastest-growing region over the forecast period. The growth can be attributed to factors such as increasing R&D activities, rising healthcare spending by governments and private organizations, growing patient awareness levels coupled with an increase in disposable income. Moreover, a large number of global contract manufacturers have set up their manufacturing facilities in this region due to low labor costs and easy availability of resources.
The Asia Pacific market was valued at USD X million in 2017 and is anticipated to grow at a CAGR of XX% from 2018 to 2030 owing high demand for advanced therapeutics that are cost-effective & efficient for treatment across various disorders including cancer & autoimmune diseases among others.
In addition, major pharmaceutical companies such as Pfizer Inc., Merck & Co., Inc.
Growth Factors:
- Increasing demand for API Contract Manufacturing from the biopharmaceutical and generic drug industries
- Proliferation of contract manufacturing organizations (CMOs) and third-party service providers
- Emergence of new technologies and platforms for API development, production, and testing
- Growing focus on quality by pharmaceutical companies to ensure patient safety
- Rising demand for cost-effective outsourcing solutions
Scope Of The Report
Report Attributes
Report Details
Report Title
API Contract Manufacturing Market Research Report
By Type
Commercial Manufacturing, Clinical Manufacturing
By Application
Oncology, Central nervous system, Cardiovascular disorder, Infectious diseases, Pulmonary disorders, Metabolic disorder, Gastrointestinal disorders, Musculoskeletal disorders, Genitourinary disorders
By Companies
AstraZeneca Plc, BoehringerIngelhein GmbH, GlaxoSmithKline Pharmaceuticals Ltd, Merck＆Co.，Inc, Novartis AG, Piramal Pharma Solutions, Ranbaxy Laboratories Ltd., Reddy's Laboratories Ltd, Sandoz-Lek-Biochemie, Sun Pharmaceutical Industries Ltd, Teva Pharmaceuticals Industries Ltd
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
200
Number of Tables & Figures
140
Customization Available
Yes, the report can be customized as per your need.
Global API Contract Manufacturing Market Report Segments:
The global API Contract Manufacturing market is segmented on the basis of:
Types
Commercial Manufacturing, Clinical Manufacturing
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Oncology, Central nervous system, Cardiovascular disorder, Infectious diseases, Pulmonary disorders, Metabolic disorder, Gastrointestinal disorders, Musculoskeletal disorders, Genitourinary disorders
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AstraZeneca Plc
- BoehringerIngelhein GmbH
- GlaxoSmithKline Pharmaceuticals Ltd
- Merck＆Co.，Inc
- Novartis AG
- Piramal Pharma Solutions
- Ranbaxy Laboratories Ltd.
- Reddy's Laboratories Ltd
- Sandoz-Lek-Biochemie
- Sun Pharmaceutical Industries Ltd
- Teva Pharmaceuticals Industries Ltd
Highlights of The API Contract Manufacturing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Commercial Manufacturing
- Clinical Manufacturing
- By Application:
- Oncology
- Central nervous system
- Cardiovascular disorder
- Infectious diseases
- Pulmonary disorders
- Metabolic disorder
- Gastrointestinal disorders
- Musculoskeletal disorders
- Genitourinary disorders
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the API Contract Manufacturing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
API Contract Manufacturing is a process that allows companies to contract with manufacturers to produce specific products or services. The company will provide specifications and the manufacturer will create the product or service based on those specifications.
Some of the major players in the api contract manufacturing market are AstraZeneca Plc_x000D_, BoehringerIngelhein GmbH_x000D_, GlaxoSmithKline Pharmaceuticals Ltd_x000D_, Merck＆Co.，Inc_x000D_, Novartis AG_x000D_, Piramal Pharma Solutions_x000D_, Ranbaxy Laboratories Ltd._x000D_, Reddy's Laboratories Ltd_x000D_, Sandoz-Lek-Biochemie_x000D_, Sun Pharmaceutical Industries Ltd_x000D_, Teva Pharmaceuticals Industries Ltd.
The api contract manufacturing market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 API Contract Manufacturing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 API Contract Manufacturing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 API Contract Manufacturing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the API Contract Manufacturing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global API Contract Manufacturing Market Size & Forecast, 2018-2028
4.5.1 API Contract Manufacturing Market Size and Y-o-Y Growth
4.5.2 API Contract Manufacturing Market Absolute $ Opportunity
Chapter 5 Global API Contract Manufacturing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 API Contract Manufacturing Market Size Forecast by Type
5.2.1 Commercial Manufacturing
5.2.2 Clinical Manufacturing
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global API Contract Manufacturing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 API Contract Manufacturing Market Size Forecast by Applications
6.2.1 Oncology
6.2.2 Central nervous system
6.2.3 Cardiovascular disorder
6.2.4 Infectious diseases
6.2.5 Pulmonary disorders
6.2.6 Metabolic disorder
6.2.7 Gastrointestinal disorders
6.2.8 Musculoskeletal disorders
6.2.9 Genitourinary disorders
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global API Contract Manufacturing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 API Contract Manufacturing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America API Contract Manufacturing Analysis and Forecast
9.1 Introduction
9.2 North America API Contract Manufacturing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America API Contract Manufacturing Market Size Forecast by Type
9.6.1 Commercial Manufacturing
9.6.2 Clinical Manufacturing
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America API Contract Manufacturing Market Size Forecast by Applications
9.10.1 Oncology
9.10.2 Central nervous system
9.10.3 Cardiovascular disorder
9.10.4 Infectious diseases
9.10.5 Pulmonary disorders
9.10.6 Metabolic disorder
9.10.7 Gastrointestinal disorders
9.10.8 Musculoskeletal disorders
9.10.9 Genitourinary disorders
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe API Contract Manufacturing Analysis and Forecast
10.1 Introduction
10.2 Europe API Contract Manufacturing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe API Contract Manufacturing Market Size Forecast by Type
10.6.1 Commercial Manufacturing
10.6.2 Clinical Manufacturing
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe API Contract Manufacturing Market Size Forecast by Applications
10.10.1 Oncology
10.10.2 Central nervous system
10.10.3 Cardiovascular disorder
10.10.4 Infectious diseases
10.10.5 Pulmonary disorders
10.10.6 Metabolic disorder
10.10.7 Gastrointestinal disorders
10.10.8 Musculoskeletal disorders
10.10.9 Genitourinary disorders
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific API Contract Manufacturing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific API Contract Manufacturing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific API Contract Manufacturing Market Size Forecast by Type
11.6.1 Commercial Manufacturing
11.6.2 Clinical Manufacturing
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific API Contract Manufacturing Market Size Forecast by Applications
11.10.1 Oncology
11.10.2 Central nervous system
11.10.3 Cardiovascular disorder
11.10.4 Infectious diseases
11.10.5 Pulmonary disorders
11.10.6 Metabolic disorder
11.10.7 Gastrointestinal disorders
11.10.8 Musculoskeletal disorders
11.10.9 Genitourinary disorders
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America API Contract Manufacturing Analysis and Forecast
12.1 Introduction
12.2 Latin America API Contract Manufacturing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America API Contract Manufacturing Market Size Forecast by Type
12.6.1 Commercial Manufacturing
12.6.2 Clinical Manufacturing
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America API Contract Manufacturing Market Size Forecast by Applications
12.10.1 Oncology
12.10.2 Central nervous system
12.10.3 Cardiovascular disorder
12.10.4 Infectious diseases
12.10.5 Pulmonary disorders
12.10.6 Metabolic disorder
12.10.7 Gastrointestinal disorders
12.10.8 Musculoskeletal disorders
12.10.9 Genitourinary disorders
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) API Contract Manufacturing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) API Contract Manufacturing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) API Contract Manufacturing Market Size Forecast by Type
13.6.1 Commercial Manufacturing
13.6.2 Clinical Manufacturing
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) API Contract Manufacturing Market Size Forecast by Applications
13.10.1 Oncology
13.10.2 Central nervous system
13.10.3 Cardiovascular disorder
13.10.4 Infectious diseases
13.10.5 Pulmonary disorders
13.10.6 Metabolic disorder
13.10.7 Gastrointestinal disorders
13.10.8 Musculoskeletal disorders
13.10.9 Genitourinary disorders
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 API Contract Manufacturing Market: Competitive Dashboard
14.2 Global API Contract Manufacturing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AstraZeneca Plc
14.3.2 BoehringerIngelhein GmbH
14.3.3 GlaxoSmithKline Pharmaceuticals Ltd
14.3.4 Merck＆Co.，Inc
14.3.5 Novartis AG
14.3.6 Piramal Pharma Solutions
14.3.7 Ranbaxy Laboratories Ltd.
14.3.8 Reddy's Laboratories Ltd
14.3.9 Sandoz-Lek-Biochemie
14.3.10 Sun Pharmaceutical Industries Ltd
14.3.11 Teva Pharmaceuticals Industries Ltd
